jeudi 6 novembre 2025

Des bouteilles parties, par BVMAC, en paiement des vidéos, voir le nombre, erreurs, le comptable étranger, la honte va tuer quelqu'un..

 Ebangue Eyoum Arnold Emmanuel sur pappers

Ebangue Eyoum Arnold Emmanuel

Lists

Watchlist
.DJI
Dow Jones Industrial Average
46,831.53
-1.01%
.INX
S&P 500
6,716.32
-1.18%
AMZN
Amazon.com Inc
$243.30
-2.76%
BCH / USD
Bitcoin Cash / United States Dollar
468.61
-4.33%
BLK
BlackRock Inc
$1,059.64
-1.30%
BNPQF
BNP Paribas SA
$74.96
0.00%
BTC / USD
Bitcoin / United States Dollar
101,008.00
-2.78%
BTC / XAF
Bitcoin / Central African CFA franc
57,505,574.91
-0.09%
BTCD
FiCAS Dynamic Crypto ETP
CHF15.00
0.00%
BTS / USD
BitShares / United States Dollar
0.00091
+9.38%
CAD / USD
Canadian Dollar / United States Dollar
0.7079
-0.17%
CAD / XAF
Canadian Dollar / Central African CFA franc
403.0776
-0.41%
CASH
Global X High Interest Savings ETF Class A
$50.01
-0.01%
CFA
VictoryShares US 500 Volatility Wtd ETF
$89.45
-0.19%
CMR
iShares Premium Money Market ETF
$50.03
0.00%
CMRCF
iShares Premium Money Market ETF
$36.42
0.00%
CORI2035
BlackRock CoRI Retirement Index 2035
10.77
-1.23%
DOGE / XOF
Dogecoin / West African CFA franc
90.5605
-4.80%
EUR / XAF
Euro / Central African CFA franc
655.9570
0.00%
GBP / XAF
Pound sterling / Central African CFA franc
744.1879
-0.02%
GLP
Global Partners LP Unit
$44.86
-0.73%
GSPX
iShares Core S&P 500 UCITS ETF GBP Hedged (Dist)
£11.30
-1.11%
IVV
iShares Core S&P 500 ETF
$672.82
-1.19%
IVVW
iShares S&P 500 BuyWrite ETF
$46.32
0.00%
JPY / XOF
Japanese Yen / West African CFA franc
3.7207
+0.48%
MAD / XAF
Moroccan Dirham / Central African CFA franc
61.1967
-0.25%
NVDA
NVIDIA Corp
$188.84
-3.27%
PKR / XOF
Pakistani Rupee / West African CFA franc
2.0137
-0.24%
PX1
CAC 40
7,964.77
-1.36%
RUT
Russell 2000 Index
2,424.47
-1.64%
SOL / XAF
Solana / Central African CFA franc
88,697.4469
-4.43%
SX5E
EURO STOXX 50
5,612.71
-1.00%
UKX
FTSE 100 Index
9,735.78
-0.42%
USD / XAF
United States Dollar / Central African CFA franc
569.2342
-0.28%
USD / XOF
United States Dollar / West African CFA franc
569.2317
-0.22%
VGX / USD
Voyager Tokens / United States Dollar
6.9251
+0.99%
XAF / USD
Central African CFA franc / United States Dollar
0.0018
+0.28%
XOF / USD
West African CFA franc / United States Dollar
0.0018
+0.28%
XOF / XAF
West African CFA franc / Central African CFA franc
1.0000
-0.00%
Equity sectors
SIXB
Materials
905.65
-0.00%
SIXC
Communications
588.36
-0.70%
SIXE
Energy
929.73
+1.17%
SIXI
Industrials
1,539.15
-0.36%
SIXM
Financials
643.67
-0.63%
SIXR
Staples
764.74
-0.27%
SIXRE
Real estate
200.71
-0.04%
SIXT
Technology
2,910.40
-2.08%
SIXU
Utilities
900.18
+0.13%
SIXV
Health care
1,470.68
-0.01%
SIXY
Discretionary
2,375.94
-2.46%
Q3 2025 earnings in 4 days
See details
Home|
OM:NASDAQ
Outset Medical Inc
11.88
-5.41%
(-0.68) Today
 Nov 6 12:08:53 PM UTC-5  ·   USD
Next call in 4 days
Mon, Nov 10, 10:30 PM
Fiscal Period
Q3 2025
Diluted EPS / Estimate
-/ (-0.66 est.)
Revenue / Estimate
-/ (30.70M est.)
Fiscal Q3 2025 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Analysts Project Q3 Revenue and EPS:Analysts are forecasting Outset Medical to report Q3 2025 revenue between $2.15 billion and $2.32 billion, with an expected net loss ranging from $72.6 million to $91.9 million for the fiscal year 2025.
Strong Demand for Tablo System:Core business metrics to watch include demand for the Tablo Console, which saw a 25% year-over-year increase in revenue in Q2 2025, and recurring revenue from cartridges and service, which grew 11% in the prior quarter.
Raised Full-Year 2025 Guidance:Following strong Q2 results, Outset Medical raised its full-year 2025 revenue guidance to a range of $122 million to $126 million, maintained expectations for a high-30% non-GAAP gross margin, and projected lower cash usage for the year.
Strategic Growth and Market Expansion:The company has demonstrated strategic growth through significant console placements, including a new enterprise agreement with a large national health system, and recently appointed a Chief Nursing Officer to lead clinical programs.
Potential Headwinds from Past Recalls:Investors may monitor any lingering impacts from an April 2024 recall of the Tablo system due to a tubing issue, which exposed patients to chemicals, though the company reported no related injuries or deaths.
Analyst Sentiment and Short Interest:Recent analyst sentiment is mixed, with some suggesting a 'Moderate Buy' rating and significant upside potential, while a recent 13.37% increase in short interest indicates decreasing investor sentiment.
What is the company's progress on its path to profitability and achieving cash flow breakeven?

How is the Tablo system performing in terms of market penetration and competitive positioning in both the acute and sub-acute settings?

Previous reports
Fiscal PeriodReport dateDiluted EPSEPS surpriseRevenueRev. surprise
Q2 2025Aug 6, 2025
-/ (-0.98 est.)
-
31.42M/ (29.41M est.)
+6.84%
Q1 2025May 7, 2025
-/ (-0.95 est.)
-
29.75M/ (27.81M est.)
+6.98%
Q4 2024Feb 19, 2025
-7.29/ (-6.19 est.)
-17.82%
29.47M/ (28.47M est.)
+3.49%
Q3 2024Nov 6, 2024
-/ (-6.33 est.)
-
28.67M/ (26.90M est.)
+6.55%
Q2 2024Aug 7, 2024
-/ (-6.79 est.)
-
27.39M/ (31.17M est.)
-12.14%
Q1 2024May 8, 2024
-/ (-8.23 est.)
-
28.17M/ (30.35M est.)
-7.17%
Q4 2023Feb 21, 2024
-11.52/ (-9.23 est.)
-24.88%
30.51M/ (30.13M est.)
+1.25%
Q3 2023Nov 7, 2023
-/ (-10.00 est.)
-
30.36M/ (30.39M est.)
-0.10%
Q2 2023Aug 2, 2023
-/ (-10.89 est.)
-
36.04M/ (34.79M est.)
+3.58%
Q1 2023May 3, 2023
-/ (-10.35 est.)
-
33.47M/ (31.76M est.)
+5.38%
Q4 2022Feb 13, 2023
-/ (-11.19 est.)
-
32.01M/ (30.92M est.)
+3.51%
Q3 2022Nov 8, 2022
-/ (-10.57 est.)
-
27.76M/ (25.23M est.)
+10.01%

Research

Ebangue sur papers
News PublisherNews PublisherNews Publisher
8 sites

You have asked for information about "Ebangue" and "papers." Since you are on a Google Finance page, and because "papers" can sometimes refer to financial reports, this is a reasonable financial query. However, the search results indicate that "Ebangue" is a common family name associated with multiple individuals and topics that are not primarily financial. Therefore, a specific financial interpretation is not appropriate.

Instead, here are some of the individuals named Ebangue and the papers they have published, based on the search results:

  • Giovanni Titti Ebangue: This researcher, affiliated with Université de Yaoundé I in Cameroon, focuses on ecology. In 2023, he published a paper on the diversity patterns of ants and termites in forest-savanna habitats in Cameroon.
  • Abel Ebongue: A Doctor of Philosophy in Electronics Engineering, he is associated with 3M. His research includes papers on electronics, such as the performance of flexible AlGaN/GaN high-electron-mobility transistors.
  • Ngando Ebongue George: Papers by this individual are available for download on OA.mg.
  • Augustin Emmanuel Ebongue: This individual's papers are also available on OA.mg.
  • Cecile Okalla Ebongue: This person has authored articles for Scientific Research Publishing.

This query does not directly relate to Outset Medical Inc (NASDAQ:OM), the stock associated with your current Google Finance page.

Outset Medical Inc

Symbols
Trend
Change
OM
Outset Medical Inc
$11.88
-5.41%
AI responses may include mistakes. For financial advice, consult a professional. Learn more
Ebangue Eyoum Arnold Emmanuel sur pappers
News Publisher
1 sites

Based on the search results, Ebangue Eyoum Arnold Emmanuel is an independent researcher with a profile on Academia.edu. The results list several collaborators but do not provide specific paper titles or links to publications. "Pappers" is a French website that provides legal and financial information about companies, but since the search results do not indicate that this individual is associated with a specific company in a capacity that would appear on Pappers, there is no relevant information available.

This query does not directly relate to Outset Medical Inc (NASDAQ:OM), the stock associated with your current Google Finance page.

Outset Medical Inc

Symbols
Trend
Change
OM
Outset Medical Inc
$11.88
-5.41%
AI responses may include mistakes. For financial advice, consult a professional. Learn more

Search for stocks, ETFs, and more
AI content may include mistakes. Learn more

Based on the search results, Ebangue Eyoum Arnold Emmanuel is an independent researcher with a profile on Academia.edu. The results list several collaborators but do not provide specific paper titles or links to publications. "Pappers" is a French website that provides legal and financial information about companies, but since the search results do not indicate that this individual is associated with a specific company in a capacity that would appear on Pappers, there is no relevant information available.

This query does not directly relate to Outset Medical Inc (NASDAQ:OM), the stock associated with your current Google Finance page.

Outset Medical Inc

Symbols
Trend
Change
Price
Change
% Change
Mkt Cap
OM
Outset Medical Inc
$11.88
-5.41%
$11.88
-0.68
-5.41%
213.02M
AI responses may include mistakes. For financial advice, consult a professional. Learn more

Aucun commentaire:

Enregistrer un commentaire

kwédi é

  ...